TipRanks
Advertisement
Advertisement
AngioCare hires renal denervation veteran to drive global Iberis therapy push
PremiumCompany AnnouncementsAngioCare hires renal denervation veteran to drive global Iberis therapy push
1M ago
Shanghai Bio-Heart Sets October EGM to Strengthen Board Independence
Premium
Company Announcements
Shanghai Bio-Heart Sets October EGM to Strengthen Board Independence
1M ago
Shanghai Bio-Heart Narrows Market Path With New Stent Approval Amid Wider Interim Loss
Premium
Company Announcements
Shanghai Bio-Heart Narrows Market Path With New Stent Approval Amid Wider Interim Loss
2M ago
Shanghai Bio-heart Wins Israel Registration for Iberis Renal Denervation System
PremiumCompany AnnouncementsShanghai Bio-heart Wins Israel Registration for Iberis Renal Denervation System
4M ago
Shanghai Bio-heart Sets 2025 AGM to Vote on Governance Overhaul and Supervisory Board Abolition
Premium
Company Announcements
Shanghai Bio-heart Sets 2025 AGM to Vote on Governance Overhaul and Supervisory Board Abolition
4M ago
Shanghai Bio-Heart Overhauls Governance Structure Ahead of 2026 AGM
Premium
Company Announcements
Shanghai Bio-Heart Overhauls Governance Structure Ahead of 2026 AGM
5M ago
Shanghai Bio-Heart’s Iberis Renal Denervation System Registered in Indonesia
PremiumCompany AnnouncementsShanghai Bio-Heart’s Iberis Renal Denervation System Registered in Indonesia
9M ago
Shanghai Bio-heart Registers Iberis® RDN System in New Zealand
Premium
Company Announcements
Shanghai Bio-heart Registers Iberis® RDN System in New Zealand
11M ago
Shanghai Bio-heart’s Iberis® RDN System Gains UK Registration
Premium
Company Announcements
Shanghai Bio-heart’s Iberis® RDN System Gains UK Registration
12M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―